Steven Woloshin

Dartmouth College — United States

Economics, Econometrics and Finance · Social Sciences

63h-index15.9kcitations264works4.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(46), Pharmaceutical industry and healthcare(36), Global Cancer Incidence and Screening(34), Pharmaceutical Economics and Policy(21), Healthcare cost, quality, practices(20)

Publications257 total

Responding to public health challenges of medical advice from social media influencers
BMJ·2025· 6 citedOpen Access
Patient and Physician Perspectives on Using Risk Prediction to Support Breast Cancer Surveillance Decision Making
Medical Decision Making·2025
Less is more for patients, practitioners, public and planet: a taxonomy for the harms of too much medicine
BMJ evidence-based medicine·2025· 5 cited
Reporting of Clinical Trial Uncertainties With New Cancer Drugs in Journal Publications and Clinical Guidelines
JAMA·2025Open Access
Health Professional Students’ Knowledge About FDA Drug and Medical Device Regulation
Academic Medicine·2025
Trends in use of the new <scp>MeSH</scp> term “overdiagnosis”: A bibliometric review
Health Information & Libraries Journal·2025· 1 citedOpen Access
Comparison of AI-assisted and human-generated plain language summaries for Cochrane reviews: protocol for a randomised trial (HIET-1) [Registered Report - stage I]
Journal of Clinical Epidemiology·2025· 1 citedOpen Access
New Cancer Drug Approvals: Less Than Half Of Important Clinical Trial Uncertainties Reported By The FDA To Clinicians, 2019–22
Health Affairs·2025· 1 cited
Communication of uncertainties about recent cancer drugs in large language models.
Journal of Clinical Oncology·2025
What evidence is required to justify the NHS Health Check programme?
BMC Medicine·2025· 3 citedOpen Access
Alternative Presentations of Overall and Statistical Uncertainty for Adults’ Understanding of the Results of a Randomized Trial of a Public Health Intervention: Parallel Web-Based Randomized Trials
JMIR Public Health and Surveillance·2025Open Access
Corrigendum to “Tobacco Product Use and Functionally Important Respiratory Symptoms Among US Adolescents/Young Adults” [Acad Pediatr. 2022; 22(6):1006–1016]
Academic Pediatrics·2025Open Access
Physician-Patient Communication about Novel Drugs and High-Risk Medical Devices
Medical Decision Making·2024· 1 citedOpen Access
Direct-to-consumer tests: emerging trends are cause for concern.
UNC Libraries·2024· 1 citedOpen Access
Direct-to-consumer tests: emerging trends are cause for concern
BMJ·2024· 15 cited
Patients deserve better information on new drugs
BMJ·2024· 5 cited
Website Content and Funding of Officially Recognized Disease Awareness Campaigns
JAMA·2024· 3 citedOpen Access
Call to improve transparent communication in direct-to-consumer test marketing
BMJ evidence-based medicine·2024· 2 cited
Alternative Presentations of Overall and Statistical Uncertainty for Adults’ Understanding of the Results of a Randomized Trial of a Public Health Intervention: Parallel Web-Based Randomized Trials (Preprint)
2024Open Access
Patient perspectives on evidence supporting drug safety and effectiveness: “What does it mean for me?”
Journal of the American Geriatrics Society·2024· 1 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Lisa M. Schwartz(42), H. Gilbert Welch(16), Renda Soylemez Wiener(6), Wolfgang Gaissmaier(3), Angela B. Mariotto(3), Gerd Gigerenzer(2), Lisa Schwartz(2), John Brodersen(2), Nadia Howlader(2), H. Cho(2), L. M. Schwartz(2), Anna N.A. Tosteson(2), Stephanie Byram(2), Baruch Fischhoff(2), Michael K. Gould(2), Robin J. Larson(2), Elke Kurz‐Milcke(1), Neeraj G. Patel(1), Aaron S. Kesselheim(1), Lyndal Trevena(1)